Carcinogenic Potential and Safety Profile of Aspartame: Metabolism, Neurotoxicity, Oxidative Stress, and Health Implications: A Review
Аннотация
Abstract Aspartame, an artificial sweetener around 200 times sweeter than sucrose, is extensively utilised worldwide in various food and beverage items owing to its low caloric value. Notwithstanding regulatory endorsements from entities like the FDA and EFSA, apprehensions over its long-term safety endure, especially in relation to neurotoxicity, oxidative stress, metabolic consequences, and carcinogenic risk. This paper rigorously analyses aspartame’s chemical characteristics, metabolic processes, safety assessment, and its effects on neurotransmission, glucose intolerance, and oxidative stress. Research demonstrates that aspartame metabolites (phenylalanine, aspartic acid, and methanol) can cause oxidative damage and neurotoxicity, particularly in susceptible groups such as those with phenylketonuria, pregnant women, and children. Epidemiological and experimental studies have not definitively associated normal aspartame intake with cancer; however, high-dose animal research indicates possible tumorigenicity. Aspartame may also induce glucose intolerance and systemic inflammation by modifying gut enzyme activity and the makeup of microbiota. The study identifies information deficiencies and calls for comprehensive, longitudinal human investigations employing modern biomarkers to thoroughly clarify aspartame’s safety and health effects. Current data substantiates the safety of aspartame within defined tolerable daily consumption limits, highlighting the necessity for prudent usage and ongoing study.